Insulet: Omnipod Users Report Persistent Leakage, Under-Delivery Problems with Insulin Devices Not Included in Prior Recall

In May, Insulet Corporation (PODD) issued a recall affecting millions of its Omnipod insulin delivery devices after some lots of the popular Omnipod 5 system, as well as the Omnipod DASH and Omnipod Eros, were found to have a small tear in the tubing just above the skin—a defect that can cause insulin to leak […]

Health Care Weekly: Pharmacists Wary of Data Sharing in CVS Caremark Settlement; FTC Touts Success of OhioHealth Probe; FDA Seeks to Speed Botanical Drug Development; CMS Announces Fraud Crackdown as Comments Close for Home Health, Hospice, DME Rule

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...

Sep 09, 2026 Read Now >

Antitrust Agenda: Collapse in Cattle Prices Following Plant Closures, Beef Imports, May Bely White House Attempts to Console Ranchers; The ‘Capacity Crunch’ at Heart of U.S. Gasoline Prices; U.S. House Ponders More Open Legislative Process; Brian Shearer on Insurance Price-Gouging Reform

Welcome to The Antitrust Agenda, our weekly analysis of timing and priorities at the FTC, DOJ, and state AG offices. Key stories we’re following this week include: • What ranchers think of USDA...

Sep 08, 2026 Read Now >

Ligado Networks: Court Ruling Puts at Risk Company’s $39 Billion Lawsuit Against U.S. Government

A Federal Claims Court judge’s ruling this week will delay—and could even derail—Ligado Networks’ effort to seek $39 billion from the U.S. government for allegedly preventing the company from...

Sep 04, 2026 Read Now >

Insulet: Omnipod Users Report Persistent Leakage, Under-Delivery Problems with Insulin Devices Not Included in Prior Recall

RELATED ARTICLES | Corporate investigations

Health Care Weekly: Pharmacists Wary of Data Sharing in CVS Caremark Settlement; FTC Touts Success of OhioHealth Probe; FDA Seeks to Speed Botanical Drug Development; CMS Announces Fraud Crackdown as Comments Close for Home Health, Hospice, DME Rule

Antitrust Agenda: Collapse in Cattle Prices Following Plant Closures, Beef Imports, May Bely White House Attempts to Console Ranchers; The ‘Capacity Crunch’ at Heart of U.S. Gasoline Prices; U.S. House Ponders More Open Legislative Process; Brian Shearer on Insurance Price-Gouging Reform

Ligado Networks: Court Ruling Puts at Risk Company’s $39 Billion Lawsuit Against U.S. Government

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.